Topic Archives: Halozyme (HALO)

Oncotutorial

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]

CellCeutix: 23 Minutes with Leo Ehrlich

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here.] “All non-denial denials. They doubt our ancestry, but they don’t say the story isn’t accurate.” —-from All the President’s […]

The Last Samurai Biotech

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. His bio, past articles, and most recent comments can be seen here. Enjoy!] OUT of the night that covers me, Black as the Pit from pole to pole, I thank […]

Comments

  • Travis Johnson, Stock Gumshoe

    That Halo Fi pitch has been circulating for over a year and a half now, they keep updating it with new dates but not cha...

  • Avatar

    What about Halo Fi touted on Stansberry? Does anyone have an idea what it is?...

  • Avatar
  • Travis Johnson, Stock Gumshoe

    The "Halo-Fi" possibility of a network of satellites, by OneWeb or SpaceX or someone else, has nothing to do with the ac...

  • Avatar

    I've been interested in Halo-Fi for quite a while and have gotten the teasers... got another one today that said it woul...

  • Avatar

    what do nyou bknow about purchasing HALO FI stock and how?...

  • Avatar

    SAN DIEGO, Oct. 22, 2018 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of ...

  • Gr8Full!

    $HALO Halozyme Announces First Clinical Dosing In Bristol-Myers Squibb's Phase 1 Trial Of BMS-986179 With Enhanze® Tech...

  • Gr8Full!

    Market Trends Toward New Normal in Halozyme Therapeutics, Fitbit, Iconix Brand Group, Leap Therapeutics, LightPath Techn...

  • Avatar

    Investor Clouseau, No question, $HALO sounds as good as it gets. But let me tell you a story. Back when I was still a...

  • Avatar

    $HALO Form 8-k filed https://fintel.io/doc/www.sec.gov/Archives/edgar/data/1159036/000115903618000005/a8-kjpm2018.htm B...

  • Avatar

    $HALO calls/options So as a newbie to options (and staying very simple for obvious reasons), I do have a question for...

  • Avatar

    $HALO L $SNDX L Goldman lists both as "attractive targets" this morning: https://seekingalpha.com/news/3321426-goldman-b...

  • Dr. KSS MD PhD

    I think it's pretty fair to disclose, especially to the hard core/corps of readers who follow the threads, that at this ...

  • Avatar

    I too have a strong interest in the timing of a potential $HALO buyout. Currently my entire position, a large one, is in...

  • Avatar

    Unfortunately, I will not be able to be on the entire conference call and will have to listen to the replay, but I hope ...

  • Avatar

    $HALO I just sent a request to the CBOE asking for a $40 January 2020 strike price for HALO to be opened up. I've hear...

  • Avatar

    $HALO Purchased some cheap calls on Friday. Expiration 2019 and 2020. Good days are ahead, I believe. Steve...

  • Avatar

    $ARTH $HALO long Bought more $ARTH yesterday to add to my already full position. Also bought more $HALO and looking ...

  • Avatar

    $HALO - regarding the posts suggesting possible collusion between analysts and institutions, isn't it obvious that it wa...

  • Avatar

    Thanks to Dr KSS's thoughts on a buyout price for HALO, I have a new strategy for how I will play HALO. I have plenty o...

  • Avatar

    $HALO If you fall on the cynical and suspicious side of the fence like myself then a very interesting experiment to u...

  • Avatar

    $HALO long Halozyme assumed with an Equal Weight from Overweight at Barclays Barclays analyst Gena Wang downgraded...

  • Avatar

    OT: $Halo Is your reasoning on near expiration’s and low strikes is that they will just cost more? I bought March 18 ...

  • Avatar

    $Halo I bought the Jan 19 $25 ones just planning to sit on them gonna hatch them like a male penguin.. Ha...

  • Avatar

    $HALO - previous high close $19.07; previous high tick $19.37 currently approx $19.20. Call option implied volatility...

  • Avatar

    $HALO Alright Gummunity, please grade my paper. Would this be a stripped down layman's summary of HALO's PEG-hyaluroni...

  • Avatar

    IMHO the most rabid shareholders are those of ZIOP and XON. They ignore Kirk's HALO. Not sure why based upon the below a...

  • Dr. KSS MD PhD

    Eight months ago? That's utter ancient history for $HALO and totally irrelevant now. Every major pharma is poking around...

  • Avatar

    As the market for HALO 2020 LEAPS is beginning to clarify with respect to reasonable pricing, I think it would be helpfu...

  • Dr. KSS MD PhD

    Mitch, I honestly don't know and am loath to soothsay. It's clear multiple major players see the virtues of PEG-hyaluron...

  • Avatar

    $HALO long What you said makes sense. I think I read something the other day where Goldman Sachs analysts see some...

  • SoGiAm

    $HALO Long added shares and Jan 2019 options :-) $MAG New long - Thank you HendrixNuzzles and the Metals Gummunity! $S...

  • Avatar

    $halo long Asking all Gummies with respect to Halo, does the proposed tax reform play a role in timing of a potential...

  • Avatar

    Doc, not to beat the $HALO horse to death, but has your opinion on the timing changed since the Q3 conference call? Prio...

  • Avatar

    $Halo long calls Hi Duck, Thanks for posting the article. Reading it there isn't a lot of information in it. Seems...

  • Dr. KSS MD PhD

    I could so have a torrid love affair with your portfolio....you know, run off to the Greek Isles with it and be all two-...

  • Avatar

    Halozyme (HALO) Pleased by FDA Approval of Genentech's RITUXAN HYCELA...

  • Avatar

    Jim Daly appointed to Board of Directors at Halozyme (HALO). http://finance.yahoo.com/news/halozyme-appoints-jim-daly...

  • arch1

    Halo news; . Eli Lilly partners with Halozyme to develop subcutaneous injectables Tuesday, December 22, 2015 | By Va...

  • Avatar

    Halozyme (HALO) article. http://www.fool.com/investing/general/2015/08/29/should-your-portfolio-say-hello-to-halozyme-t...

  • Avatar

    Halozyme (HALO) PEGPH20 putting up some impressive results in progression free survival. http://journals.lww.com/oncol...

  • Avatar

    $HALO University of California, San Francisco (UCSF) To Study Halozyme (HALO) PEGPH20 In Pancreatic Cancer Patients Who...

  • Avatar

    $HALO HN - I'd keep my eye on the prize. As Dr. KSS emphasized in one of stock round-up posts last month: Halozyme $...

  • Avatar

    Halozyme (HALO) mentioned here as a prime takeover candidate. http://www.investorsalley.com/when-big-pharma-comes-a-cal...

  • Avatar

    Vanguard takes 5% stake in Halozyme (HALO). http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0000932471-15-0047...

  • Dr. KSS, MD PhD

    Glenn, I fear Verastem is one of those companies that has started out with the soundest of science and is now officially...

  • Dr. KSS, MD PhD

    I thought Dr. Helen Torley, the new Scottish CEO of Halozyme $HALO did a good job on TV last night. That's what HALO has...

  • Avatar

    Halozyme (HALO) provides updates for milestones for 2015. http://finance.yahoo.com/news/halozyme-therapeutics-provides-...

  • Dr. KSS, MD PhD

    I took a long position at mid-day in Halozyme ($HALO). Some may recall I have previously been negative on this stock bec...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch